How do I screen for bipolar disorder in a patient with depressive symptoms identified on the Patient Health Questionnaire‑9?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Screening for Bipolar Disorder in Patients with Depressive Symptoms

When a patient screens positive for depression on the PHQ-9, you must actively screen for bipolar disorder using the Mood Disorder Questionnaire (MDQ) before initiating antidepressant therapy, as treating unrecognized bipolar disorder with antidepressants alone carries significant risks of inducing mania or rapid cycling. 1, 2

Why Bipolar Screening is Critical in Depression

  • More than 1 in 5 primary care patients presenting with depression actually have bipolar disorder 3
  • The most common presentation of bipolar disorder is depression, not mania 3
  • Approximately 10% of primary care patients screen positive for lifetime bipolar disorder 2
  • The average time to correct diagnosis is 10 years, with half of patients consulting 3 or more professionals before receiving accurate diagnosis 3
  • Misdiagnosis leads to inappropriate antidepressant monotherapy, which can worsen outcomes 2

The Screening Algorithm

Step 1: Administer the Mood Disorder Questionnaire (MDQ)

  • The MDQ is the most widely used and validated screening tool for bipolar disorder in primary care settings 1, 3, 4
  • Use a cut-off score of 5 or higher on the MDQ, which provides sensitivity of 0.91 and specificity of 0.67 1
  • The MDQ has superior accuracy and feasibility compared to the Hypomania Checklist (HCL-32) in busy primary care settings 1

Step 2: Look for Clinical Features That Increase Bipolar Likelihood

When evaluating patients with positive PHQ-9 scores, specifically assess for:

  • Age of onset in late teens to early twenties (bipolar disorder typically starts earlier than unipolar depression) 3
  • Comorbid anxiety disorders (present in nearly all bipolar patients) 3
  • Panic disorder (significantly more common in MDQ-positive patients) 1
  • Smoking habit (associated with positive bipolar screening) 1
  • Substance use disorders (frequently comorbid) 2
  • Family history of bipolar disorder 3

Step 3: Review Treatment Response History

  • Poor or paradoxical response to antidepressant treatment is a red flag for undiagnosed bipolar disorder 4, 2
  • Only 8.4% of patients who screen positive for bipolar disorder report receiving the correct diagnosis 2
  • Only 6.5% of bipolar-positive screeners are taking appropriate mood-stabilizing agents 2

Critical Pitfalls to Avoid

  • Never initiate antidepressant monotherapy without first screening for bipolar disorder in patients presenting with depression, as this can induce mania or rapid cycling 2
  • Do not assume that absence of current manic symptoms rules out bipolar disorder—the depressive phase is the most common presentation 3
  • Do not rely solely on spontaneous patient reporting of manic symptoms; patients often lack insight into hypomanic episodes and require structured screening 3, 4
  • Recognize that primary care physicians frequently miss bipolar disorder even when depression is documented—administrative records show no bipolar diagnoses despite 9.8% positive screening rates 2

When MDQ Screens Positive

  • Refer to psychiatry for formal diagnostic evaluation using DSM criteria 1
  • Document the positive screen and hold antidepressant initiation until psychiatric consultation is completed 2
  • Recognize that patients screening positive for bipolar disorder have significantly worse health-related quality of life and increased social/family impairment compared to those with unipolar depression 2

Special Considerations

  • Higher PHQ-9 scores correlate with higher MDQ scores, so patients with more severe depression symptoms warrant particularly careful bipolar screening 1
  • Screening for bipolar disorder in high-risk samples (those with known depression) is more successful than community screening, though still requires clinical judgment 5
  • The positive predictive value of bipolar screening improves substantially when used in patients already identified with depressive symptoms rather than unselected populations 5

Related Questions

How should I screen for bipolar disorder risk in a patient before initiating sertraline (25 mg) and discontinuing finasteride, including family history and using the Mood Disorder Questionnaire?
In a patient with an MDQ (Mood Disorder Questionnaire) score of 10, a GAD‑7 (Generalized Anxiety Disorder) score of 17, a PHQ‑9 (depression) score of 13, and an ASRS (Adult ADHD Self‑Report Scale) score of 57, what is the best treatment approach and which condition should be treated first?
What assessment questions should be asked to evaluate a patient for bipolar disorder, covering manic and depressive episodes, safety, substance use, psychiatric and medical history, family history, and comorbid conditions?
What is the recommended criteria and time frame for diagnosing bipolar disorder?
What is the average time from symptom onset to bipolar disorder diagnosis?
Can hypothyroidism delay linear growth in adolescents?
What are the causes of heliotrope eyelid discoloration (violet‑purple periorbital rash)?
How should I evaluate and manage a postmenopausal woman with an unexpectedly elevated serum progesterone level?
What is the recommended management of a patient who wakes up with new neurological deficits suggestive of an acute ischemic stroke (wake‑up stroke)?
How can I distinguish progressive supranuclear palsy from multiple system atrophy and idiopathic Parkinson disease, and what are the appropriate management strategies for each?
What percentage of patients with isolated upper‑extremity deep‑vein thrombosis develop a concurrent pulmonary embolism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.